SCHEMBL4644776

SCHEMBL4644776

c1cc(COCC2CCC3OC3C2)ccc1COCC1CCC2OC2C1

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.39
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSK P43235 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16262383 0.95 NAAA (0.46) NAAACTSLCTSBCTSK
SCHEMBL28732218 0.92 AGXT (0.36) NAAACTSLCTSBCTSK
SCHEMBL5273926 0.92 CTSL (0.49) NAAACTSLCTSBCTSK
SCHEMBL16273343 0.90 CTSL (0.33) NAAACTSLCTSBCTSK
SCHEMBL13086090 0.85 CTSL (0.44) NAAACTSLCTSBCTSK
SCHEMBL19375724 0.83 CTSL (0.30) CTSLCTSBCTSK
SCHEMBL216588 0.81
Resorcinol SCHEMBL20184146 0.78 CHRNB2 (0.39)
SCHEMBL291993 0.77 TSHR (0.32)
SCHEMBL6885906 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4091578-B1 METHOD FOR PRODUCING PLATE DENTURE TOKUYAMA DENTAL CORP (JP) 2024-10-09 EP disclosed
US-11857385-B2 Method of producing plate denture, curable composition for stereolithography, and plate denture production kit TOKUYAMA DENTAL CORPORATION (JP) 2024-01-02 US disclosed
CN-114929158-B Method for producing denture, curable composition for photoforming, and kit for producing denture 株式会社德山齿科 2023-10-20 CN disclosed
US-20230320940-A1 PHOTOCATIONICALLY CURABLE COMPOSITION AND DENTAL CURABLE COMPOSITION TOKUYAMA DENTAL CORPORATION (JP) 2023-10-12 US disclosed
EP-4194477-A1 PHOTOCATIONIC CURABLE COMPOSITION AND CURABLE DENTAL COMPOSITION Tokuyama Dental Corporation (JP) 2023-06-14 EP disclosed
US-20230137898-A1 METHOD OF PRODUCING PLATE DENTURE, CURABLE COMPOSITION FOR STEREOLITHOGRAPHY, AND PLATE DENTURE PRODUCTION KIT TOKUYAMA DENTAL CORPORATION (JP) 2023-05-04 US disclosed
EP-4091578-A1 METHOD FOR PRODUCING PLATE DENTURE, CURABLE STEREOLITHOGRAPHIC COMPOSITION, AND PLATE DENTURE PRODUCTION KIT Tokuyama Dental Corporation (JP) 2022-11-23 EP disclosed
CN-114929158-A Method for producing a denture, curable composition for photo-molding, and kit for producing a denture 株式会社德山齿科 2022-08-19 CN disclosed
US-8900775-B2 Hologram recording material and hologram recording medium TDK CORPORATION (JP) 2014-12-02 US disclosed
US-20130034805-A1 HOLOGRAM RECORDING MATERIAL AND HOLOGRAM RECORDING MEDIUM TDK CORPORATION (JP) 2013-02-07 US disclosed
EP-1591098-B1 Cationically curable composition for dental use TOKUYAMA CORP (JP) 2008-08-13 EP disclosed
US-7365106-B2 Cationically curable composition for dental use TOKUYAMA CORPORATION (JP) 2008-04-29 US disclosed
US-20050250868-A1 Cationically curable composition for dental use TOKUYAMA CORPORATION (JP) 2005-11-10 US disclosed
EP-1591098-A1 Cationically curable composition for dental use TOKUYAMA CORPORATION (JP) 2005-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320940-A1 PHOTOCATIONICALLY CURABLE COMPOSITION AND DENTAL CURABLE COMPOSITION CTH, GCLC, AAAS NAAA 522/4885CTSL 2209/4885CTSB 3108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.